BPC Instruments AB CEO Jing Liu participated in an interview with Analyst Group on BPC’s business segments, market outlook, and plans for growth.

BPC Instruments (formerly Bioprocess Control Sweden AB) is a technology and market leader in the area of advanced instrumentation and control technologies for research and commercial applications in a wide range of industries. The company was founded in 2005 by scientists from Lund University, and brings to market more than 20 years of industry leading research in the area of instrumentation, control and automation of anaerobic digestion processes. Today BPC Instruments exports to more than 90 countries. BPC Instruments has a broad product portfolio covering biochemical methane potential (BMP) tests, substrate analysis, process simulation, gas flow measurements as well as a series of bioreactors. #AMPTS – the Automatic Methane Potential Test System has quickly become the preferred analytical instrument around the world. It is used by both academic and industrial actors in the biogas industry, and lately for other applications too, e.g. wastewater treatment, animal nutrition, bioplastics biodegradability and biohydrogen. BPC Instruments is listed on Spotlight Stock Market in Sweden under the ticker: BPCINS

Founded 2005